Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Journal of Medicinal Chemistry
|
February 5, 2026
Discovery and Optimization of 4-Aminopteridin-7(8<i>H</i>)-one Derivatives as Potent and Selective mTOR Inhibitors with Favorable Pharmacodynamic and Safety Characteristics
Danyang Wang, Gengwu Li, Jianguang Liu, et al.
Plos One
|
May 10, 2014
Association mapping for epistasis and environmental interaction of yield traits in 323 cotton cultivars under 9 different environments
Yinhua Jia, Xiwei Sun, Junling Sun, et al.
Plant Disease
|
March 8, 2023
<i>GbCYP72A1</i> Improves Resistance to Verticillium Wilt via Multiple Signaling Pathways
Jianwen Xu, Jun Zhao, Jianguang Liu, et al.
Plants (Basel, Switzerland)
|
September 23, 2022
Membrane Localized GbTMEM214s Participate in Modulating Cotton Resistance to Verticillium Wilt
Jun Zhao, Jianwen Xu, Yueping Wang, et al.
ACS Medicinal Chemistry Letters
|
June 22, 2019
4-Aryl Pyrrolidines as Novel Orally Efficacious Antimalarial Agents. Part 2: 2-Aryl-<i>N</i>-(4-arylpyrrolidin-3-yl)acetamides
Marvin J Meyers, Jianguang Liu, Zhijun Liu, et al.
The Journal of Headache and Pain
|
April 16, 2024
Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial
Shengyuan Yu, Aihong Guo, Zhen Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 9, 2026
Structure-guided design of 7-azaindole DNMT1 inhibitors active against hypomethylating agent-resistant acute myeloid leukemia
Shibing Tang, Liangyi Zong, Shuyuan Ma, et al.
The Lancet. Neurology
|
May 20, 2023
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
Shengyuan Yu, Byung-Kun Kim, Aihong Guo, et al.
Cephalalgia : an International Journal of Headache
|
October 9, 2025
Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China
Mingjie Zhang, Aihong Guo, Jin Wu, et al.
BMC Genomics
|
June 14, 2018
Dissection of complicate genetic architecture and breeding perspective of cottonseed traits by genome-wide association study
Xiongming Du, Shouye Liu, Junling Sun, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Journal of Medicinal Chemistry
|
February 5, 2026
Discovery and Optimization of 4-Aminopteridin-7(8<i>H</i>)-one Derivatives as Potent and Selective mTOR Inhibitors with Favorable Pharmacodynamic and Safety Characteristics
Danyang Wang, Gengwu Li, Jianguang Liu, et al.
Plos One
|
May 10, 2014
Association mapping for epistasis and environmental interaction of yield traits in 323 cotton cultivars under 9 different environments
Yinhua Jia, Xiwei Sun, Junling Sun, et al.
Plant Disease
|
March 8, 2023
<i>GbCYP72A1</i> Improves Resistance to Verticillium Wilt via Multiple Signaling Pathways
Jianwen Xu, Jun Zhao, Jianguang Liu, et al.
Plants (Basel, Switzerland)
|
September 23, 2022
Membrane Localized GbTMEM214s Participate in Modulating Cotton Resistance to Verticillium Wilt
Jun Zhao, Jianwen Xu, Yueping Wang, et al.
ACS Medicinal Chemistry Letters
|
June 22, 2019
4-Aryl Pyrrolidines as Novel Orally Efficacious Antimalarial Agents. Part 2: 2-Aryl-<i>N</i>-(4-arylpyrrolidin-3-yl)acetamides
Marvin J Meyers, Jianguang Liu, Zhijun Liu, et al.
The Journal of Headache and Pain
|
April 16, 2024
Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial
Shengyuan Yu, Aihong Guo, Zhen Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 9, 2026
Structure-guided design of 7-azaindole DNMT1 inhibitors active against hypomethylating agent-resistant acute myeloid leukemia
Shibing Tang, Liangyi Zong, Shuyuan Ma, et al.
The Lancet. Neurology
|
May 20, 2023
Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial
Shengyuan Yu, Byung-Kun Kim, Aihong Guo, et al.
Cephalalgia : an International Journal of Headache
|
October 9, 2025
Rimegepant for the acute treatment of migraine: A phase 3, multicenter, open-label, long-term safety and effectiveness study in adults from China
Mingjie Zhang, Aihong Guo, Jin Wu, et al.
BMC Genomics
|
June 14, 2018
Dissection of complicate genetic architecture and breeding perspective of cottonseed traits by genome-wide association study
Xiongming Du, Shouye Liu, Junling Sun, et al.
Page
of 5